Advertisement
Australia markets closed

  • ALL ORDS

    7,994.10
    -30.00 (-0.37%)
     

  • AUD/USD

    0.6634
    -0.0056 (-0.84%)
     

  • ASX 200

    7,737.10
    -23.90 (-0.31%)
     

  • OIL

    72.72
    -1.50 (-2.02%)
     

  • GOLD

    2,352.50
    -16.80 (-0.71%)
     

  • Bitcoin AUD

    103,909.84
    -132.99 (-0.13%)
     

  • CMC Crypto 200

    1,442.89
    -4.26 (-0.29%)
     

Drugs giant GSK says net profits soar

AFP
GSK's ernings after tax surged to £8.089 billion ($12.3 billion, 11.0 billion euros) in the three months to the end of March

British drugmaker GlaxoSmithKline on Wednesday said its net profit rocketed in the first quarter on a vast exceptional gain following a deal with Swiss peer Novartis.

Earnings after tax surged to £8.089 billion ($12.3 billion, 11.0 billion euros) in the three months to the end of March, compared with £668 million in the same period a year earlier, GSK said in a results statement.

GSK took an exceptional gain of £9.262 billion before tax -- or £7.342 billion after tax -- on the Novartis transaction which completed in the first quarter.

GSK sold its oncology business to Novartis for $16 billion, while buying the Swiss group's vaccines division in return.

The pair also formed a joint venture for consumer health products.